Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04297696
Other study ID # 89/55
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2020
Est. completion date June 2, 2020

Study information

Verified date November 2020
Source Cukurova University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Arthropathy characterized by synovitis, cartilage degeneration, subchondral and interosseous cysts occur due to hemorrhage in hemophilia. This situation causes to chronic pain, decreasing in range of motion, muscle strength, proprioception. Disorders in these parameters are the main causes of gait dysfunction. The aim of this study is to investigate the effects of therapeutic exercises on target joint functions and gait kinematics, and to determine possible complications related to exercise in hemophilic patients.


Recruitment information / eligibility

Status Completed
Enrollment 19
Est. completion date June 2, 2020
Est. primary completion date June 1, 2020
Accepts healthy volunteers No
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria: - To be diagnosed as Hemophilia A or Hemophilia B - To be over 18 years old - To have hemophilic arthropathy in at least one joint - Undergoing prophylaxis or factor VIII-IX replacement therapy Exclusion Criteria: - Having another congenital coagulopathy, such as Von Willebrand syndrome - To be unable to walk due to hemophilic arthropathy - Having another musculoskeletal problem - Individuals with inhibitors against Factor VIII-IX

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Therapeutic exercises
A program including warm-up period and neuromuscular exercises is applied progressively in two phases.

Locations

Country Name City State
Turkey Cukurova University Gym Adana

Sponsors (1)

Lead Sponsor Collaborator
Cukurova University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Haemophilia Joint Health Score Haemophilia Joint Health Score (HJHS) will be applied to evaluate the joint functions of hemophilic individuals. HJHS is a sensitive and valid test used to determine the severity of clinical symptoms that result from hemarthrosis. This comprises an assessment of joints with regards to swelling, muscle atrophy, crepitus, range of motion, joint pain, strength, and global gait. The score for each joint is summed to obtain a total score ranging from 0 to 124, where no joint damage is indicated by a score of 0. Baseline, Change from baseline HJHS at 2 months, Change from baseline HJHS at 6 months
Primary Range of Motion Analysis with Kinovea Software Range of motion (ROM) analysis during gait will be done by analyzing video images with computer software "Kinovea". Kinovea is a free software used by sports and healthcare professionals to analyze video images during physical activity. Furthermore, it is a sensitive method that can be used to evaluate the range of motion of the lower limb joints during gait. ROM analysis of the ankle and knee joints will be done with Kinovea in the heel strike-midstance-toe off and mid-swing phases. Baseline, Change from baseline range of motion during gait at 2 months, Change from baseline range of motion during gait at 6 months.
Secondary Haemophilia Quality of Life Questionnaire for Adults The Haem-A-QoL questionnaire including 10 sections and 46 questions was used to evaluate the changes in the Quality of life of PwH; low scores indicate high QoL Baseline, Change from baseline 6min-WT at 2 months, Change from baseline Quality of life at 6 months
Secondary Six Minutes Walking Test Six-Minutes Walking Test (6min-WT) will be applied to determine the effects of therapeutic exercises on the aerobic capacity of hemophilic individuals. This test is a valid and reliable method for determining aerobic capacity in patients with neuromuscular problems. High walking distance indicates high aerobic capacity. Baseline, Change from baseline 6min-WT at 2 months, Change from baseline 6min-WT at 6 months
See also
  Status Clinical Trial Phase
Completed NCT01232634 - Validation of Ultrasound as a Diagnostic Tool for Assessment of Hemophilic Arthropathy of Knees and Ankles Phase 2
Completed NCT02994147 - A Proof-of-Concept Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Hemophilic Arthropathy Phase 2
Completed NCT02601170 - Platelet-Rich Plasma Intra-Articular Injection in Treating Hemophilic Arthropathy N/A
Terminated NCT04684511 - Rofecoxib Efficacy and Safety Evaluation Trial in Hemophilic Arthropathy Phase 3
Recruiting NCT05517070 - Vitamin D Deficiency and Body Composition in the Patients With Hemophilia
Completed NCT04535180 - Sarcopenia and Osteoporosis in the Patients With Hemophilia
Terminated NCT02569359 - Efficacy and Safety of Shea Nut Oil in Hemophilic Arthropathy N/A